IMMUNOGENIC COMPOSITION

The present application discloses an immunogenic composition comprising at least 2 different N. meningitidis capsular saccharides, wherein one or more is/are selected from a first group consisting of MenA, MenC, MenY and MenW which is/are conjugated through a linker to a carrier protein(s), and one...

Full description

Saved in:
Bibliographic Details
Main Authors DUVIVIER, Pierre@GlaxoSmithKline Biologicals s.a, POOLMAN, Jan@GlaxoSmithKline Biologicals s.a, CAPIAU, Carine@GlaxoSmithKline Biologicals s.a, BOUTRIAU, Dominique@GlaxoSmithKline Biologicals s.a, DENOEL, Philippe@GlaxoSmithKline Biologicals s.a, BIEMANS, Ralph L.@GlaxoSmithKline Biologicals s.a
Format Patent
LanguageEnglish
Hungarian
Published 30.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present application discloses an immunogenic composition comprising at least 2 different N. meningitidis capsular saccharides, wherein one or more is/are selected from a first group consisting of MenA, MenC, MenY and MenW which is/are conjugated through a linker to a carrier protein(s), and one or more different saccharides is/are selected from a second group consisting of MenA, MenC, MenY and MenW which is/are directly conjugated to a carrier protein(s).
Bibliography:Application Number: HUE06754582